Riskpilot← Back to searchSign inGet full accessDelta Medica AB
ABActiveOrg 5594118977Skogsbrynsvägen 7Medical specialists activities · NACE 8622Est. 20220 employees
Revenue 2025
SEK 0
EBITDA margin
—
-142% vs 2024
Equity ratio
51.7%
Financial strength
Net profit 2025
SEK -20K
-153% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -19K | -142% |
| Net profit | SEK -20K | -153% |
| Total assets | SEK 78K | -39% |
| Equity | SEK 40K | -33% |
| Employees | 0 | — |
Legal name
Delta Medica AB
Org number
5594118977
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
13 december 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-11-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva hälso- och sjukvård, psykoterapi, estetiskt medicin, utbildning och handledning samt annan därmed förenlig verksamhet. Bolaget ska även bedriva konsulttjänster, läkartjänster och andra förenliga läkaruppdrag mot privata vårdgivare samt uthyrning av personal i syfte att vårda och behandla patienter.
Address
Skogsbrynsvägen 7
Email
munir.tchaitchian@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 165 | 59 | 0 |
| Staff expenses | — | — | — |
| EBITDA | 143 | 46 | −19 |
| Depreciation & amort. | — | — | — |
| EBIT | 143 | 46 | −19 |
| Net financials | −0 | 0 | −0 |
| Profit before tax | 142 | 47 | −20 |
| Tax | −30 | −10 | — |
| Net profit | 113 | 37 | −20 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 172 | 127 | 78 |
| Equity | 138 | 60 | 40 |
| Long-term debt | — | 28 | 28 |
| Short-term debt | 34 | 39 | 10 |
| Total debt | 34 | 67 | 38 |
EBITDA margin
-1929300.0%
This company
15.8%
Market median
-12210859% vs market
20232025
Equity ratio
51.7%
This company
38.2%
Market median
+35% vs market
20232025
Return on equity
-48.9%
This company
18.4%
Market median
-366% vs market
20232025
Net profit margin
-1966700.0%
This company
8.1%
Market median
-24280347% vs market
20232025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20232025
Debt / equity
0.93×
This company
0.62×
Market median
+50% vs market
20232025
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MT Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Delta Medica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Munir Tchaitchian | Chief Executive Officer | 0 companies |
| Katarzyna Zelent | Deputy Board Member | 0 companies |